These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 228594)

  • 41. 3,4-Dihydro-2-phenyl-2H-pyrano[2,3-b]pyridines with potent antirhinovirus activity.
    Bargar TM; Dulworth JK; Kenny MT; Massad R; Daniel JK; Wilson T; Sargent RN
    J Med Chem; 1986 Sep; 29(9):1590-5. PubMed ID: 3018241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.
    Ledford RM; Patel NR; Demenczuk TM; Watanyar A; Herbertz T; Collett MS; Pevear DC
    J Virol; 2004 Apr; 78(7):3663-74. PubMed ID: 15016887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis of syn and anti isomers of 6-[[(hydroxyimino)phenyl]methyl]-1-[(1-methylethyl)sulfonyl]-1H-benzimidazol-2-amine. Inhibitors of rhinovirus multiplication.
    Wikel JH; Paget CJ; DeLong DC; Nelson JD; Wu CY; Paschal JW; Dinner A; Templeton RJ; Chaney MO; Jones ND; Chamberlin JW
    J Med Chem; 1980 Apr; 23(4):368-72. PubMed ID: 6247489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and antirhinovirus activity of 8-substituted analogues of 6-(dimethylamino)-9-(4-methylbenzyl)-2-(trifluoromethyl)-9H-purine.
    Kelley JL; Linn JA; Selway JW
    J Med Chem; 1991 Jan; 34(1):157-60. PubMed ID: 1846916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and anti-rhinovirus properties of fluoro-substituted flavonoids.
    Conti C; Mastromarino P; Goldoni P; Portalone G; Desideri N
    Antivir Chem Chemother; 2005; 16(4):267-76. PubMed ID: 16130524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study of the parameters of binding of R 61837 to human rhinovirus 9 and immunobiochemical evidence of capsid-stabilizing activity of the compound.
    Moeremans M; De Raeymaeker M; Daneels G; De Brabander M; Aerts F; Janssen C; Andries K
    Antimicrob Agents Chemother; 1992 Feb; 36(2):417-24. PubMed ID: 1318682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Virucidal activity of glutaric acid and evidence for dual mechanism of action.
    Kuhrt MF; Fancher MJ; McKinlay MA; Lennert SD
    Antimicrob Agents Chemother; 1984 Dec; 26(6):924-7. PubMed ID: 6098222
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Des-aspartate-angiotensin I exerts antiviral effects and attenuates ICAM-1 formation in rhinovirus-infected epithelial cells.
    Ang LT; Tan LY; Chow VT; Sim MK
    Eur J Pharmacol; 2012 May; 683(1-3):310-5. PubMed ID: 22387854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Some compounds active as antirhinovirus in the plaque inhibition test.
    Runti C
    J Med Chem; 1968 Jul; 11(4):897-9. PubMed ID: 4299535
    [No Abstract]   [Full Text] [Related]  

  • 50. Zinc ions inhibit replication of rhinoviruses.
    Korant BD; Kauer JC; Butterworth BE
    Nature; 1974 Apr; 248(449):588-90. PubMed ID: 4363085
    [No Abstract]   [Full Text] [Related]  

  • 51. Antiviral effect of hyperthermic treatment in rhinovirus infection.
    Conti C; De Marco A; Mastromarino P; Tomao P; Santoro MG
    Antimicrob Agents Chemother; 1999 Apr; 43(4):822-9. PubMed ID: 10103186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of rhinovirus replication in in organ culture by a potential antiviral drug.
    DeLong DC; Reed SE
    J Infect Dis; 1980 Jan; 141(1):87-91. PubMed ID: 6245149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and structure-activity relationships of 2-substituted-6-(dimethylamino)-9-(4-methylbenzyl)-9H-purines with antirhinovirus activity.
    Kelley JL; Linn JA; Selway JW
    J Med Chem; 1989 Jan; 32(1):218-24. PubMed ID: 2535875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antivirus agent, Ro 09-0410, binds to rhinovirus specifically and stabilizes the virus conformation.
    Ninomiya Y; Ohsawa C; Aoyama M; Umeda I; Suhara Y; Ishitsuka H
    Virology; 1984 Apr; 134(2):269-76. PubMed ID: 6100571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and antirhinovirus activity of 6-(dimethylamino)-2-(trifluoromethyl)-9-(substituted benzyl)-9H-purines.
    Kelley JL; Linn JA; Selway JW
    J Med Chem; 1989 Aug; 32(8):1757-63. PubMed ID: 2547069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating.
    Rozhon E; Cox S; Buontempo P; O'Connell J; Slater W; De Martino J; Schwartz J; Miller G; Arnold E; Zhang A
    Antiviral Res; 1993 May; 21(1):15-35. PubMed ID: 8391247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterocyclic pharmacochemistry of new rhinovirus antiviral agents: A combined computational and experimental study.
    Da Costa L; Scheers E; Coluccia A; Rosetti A; Roche M; Neyts J; Terme T; Cirilli R; Mirabelli C; Silvestri R; Vanelle P
    Eur J Med Chem; 2017 Nov; 140():528-541. PubMed ID: 28987610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiviral activity in tissue culture systems of bis-benzimidazoles, potent inhibitors of rhinoviruses.
    Schleicher JB; Aquino F; Rueter A; Roderick WR; Appell RN
    Appl Microbiol; 1972 Jan; 23(1):113-6. PubMed ID: 4333892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resveratrol inhibits rhinovirus replication and expression of inflammatory mediators in nasal epithelia.
    Mastromarino P; Capobianco D; Cannata F; Nardis C; Mattia E; De Leo A; Restignoli R; Francioso A; Mosca L
    Antiviral Res; 2015 Nov; 123():15-21. PubMed ID: 26296578
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes.
    Wyde PR; Six HR; Wilson SZ; Gilbert BE; Knight V
    Antimicrob Agents Chemother; 1988 Jun; 32(6):890-5. PubMed ID: 2843086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.